Devonyu
- Shares of Relay Therapeutics (NASDAQ:RLAY) were up 6% in midday trading Wednesday after the company reported positive updated interim data from an early-stage clinical trial for its drug RLY-2608 in the treatment of breast cancer.
- The data showed a median